Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology
Volume 27, Issue 7, Pages 414-416
http://dx.doi.org/10.1155/2013/273856
Original Article

Pretreatment Resistance to Hepatitis C Virus Protease Inhibitors Boceprevir/Telaprevir in Hepatitis C Subgenotype 1A-Infected Patients from Manitoba

Anton Andonov,1 Kamran Kadkhoda,2 Carla Osiowy,1 and Kelly Kaita3

1Public Health Agency of Canada, National Microbiology Laboratory, Winnipeg, Manitoba, Canada
2Cadham Provincial Laboratory, Winnipeg, Manitoba, Canada
3University of Manitoba, Department of Internal Medicine, Winnipeg, Manitoba, Canada

Received 7 January 2013; Accepted 21 February 2013

Copyright © 2013 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Anton Andonov, Kamran Kadkhoda, Carla Osiowy, and Kelly Kaita, “Pretreatment Resistance to Hepatitis C Virus Protease Inhibitors Boceprevir/Telaprevir in Hepatitis C Subgenotype 1A-Infected Patients from Manitoba,” Canadian Journal of Gastroenterology, vol. 27, no. 7, pp. 414-416, 2013. https://doi.org/10.1155/2013/273856.